Aldehyde dehydrogenase 2 and head and neck cancer: A meta-analysis implementing a mendelian randomization approach

Stefania Boccia, Mia Hashibe, Paola Gallì, Emma De Feo, Takahiro Asakage, Tomoko Hashimoto, Akio Hiraki, Takahiko Katoh, Takeshi Nomura, Akira Yokoyama, Cornelia M. Van Duijn, Gualtiero Ricciardi, Paolo Boffetta

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Alcohol drinkinga thigh doses is a risk factor for head and neck cancer, and exposure to acetaldehyde, the principle metabolite of alcohol, is supposed to account for the increased risk. Individuals homozygous for the *2 variant allele of aldehyde dehydrogenase 2 (ALDH2) are unable tometabolize acetaldehyde, which prevents them from alcohol drinking, whereas *1*2 have 6-fold higher blood acetaldehyde concentration postalcohol consumption with respect to *1*1. Accordingto the concept of Mendelian randomization, because this polymorphism is distributed randomly duringg amete formation, its association with head and neck cancer should be not confounded by smoking. We carried out a meta-analysis of ALDH2 and head and neck cancer searchingfo r relevant studies on Medline and Embase up to January 31, 2008, and investigated the consistency between the expected odds ratio (OR) amongd rinkers from the largest pooled analysis amongne ver smokers and the observed OR from thismeta-analysis by an interaction test. Six studies were selected (945 cases, 2,917 controls). The OR of head and neck cancer among *2*2 was 0.53 [95% confidence interval (95% CI), 0.28-1.00] relative to *1*1 and 1.83 (95% CI, 1.21-2.77) among *1*2. The expected OR for head and neck cancer due to alcohol intake among *1*1 was 1.38 (95% CI, 0.88-2.17) and the observed OR among *1*1 compared with 2*2 from this meta-analysis was 1.88 (95% CI, 1.00-3.57; P for interaction = 0.43). Besides showing the effectiveness of the Mendelian randomization approach, these findings support the theory that alcohol increases head and neck cancer risk through the carcinogenic action of acetaldehyde.

Original languageEnglish
Pages (from-to)248-254
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Aldehyde Dehydrogenase
Head and Neck Neoplasms
Random Allocation
Meta-Analysis
Acetaldehyde
Odds Ratio
Alcohols
Confidence Intervals
Thigh
Alcohol Drinking
Smoking
Alleles

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Aldehyde dehydrogenase 2 and head and neck cancer : A meta-analysis implementing a mendelian randomization approach. / Boccia, Stefania; Hashibe, Mia; Gallì, Paola; De Feo, Emma; Asakage, Takahiro; Hashimoto, Tomoko; Hiraki, Akio; Katoh, Takahiko; Nomura, Takeshi; Yokoyama, Akira; Van Duijn, Cornelia M.; Ricciardi, Gualtiero; Boffetta, Paolo.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 1, 01.2009, p. 248-254.

Research output: Contribution to journalArticle

Boccia, S, Hashibe, M, Gallì, P, De Feo, E, Asakage, T, Hashimoto, T, Hiraki, A, Katoh, T, Nomura, T, Yokoyama, A, Van Duijn, CM, Ricciardi, G & Boffetta, P 2009, 'Aldehyde dehydrogenase 2 and head and neck cancer: A meta-analysis implementing a mendelian randomization approach', Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 1, pp. 248-254. https://doi.org/10.1158/1055-9965.EPI-08-0462
Boccia, Stefania ; Hashibe, Mia ; Gallì, Paola ; De Feo, Emma ; Asakage, Takahiro ; Hashimoto, Tomoko ; Hiraki, Akio ; Katoh, Takahiko ; Nomura, Takeshi ; Yokoyama, Akira ; Van Duijn, Cornelia M. ; Ricciardi, Gualtiero ; Boffetta, Paolo. / Aldehyde dehydrogenase 2 and head and neck cancer : A meta-analysis implementing a mendelian randomization approach. In: Cancer Epidemiology Biomarkers and Prevention. 2009 ; Vol. 18, No. 1. pp. 248-254.
@article{d3a58289027149c7b5b0f3b5fc8bc35e,
title = "Aldehyde dehydrogenase 2 and head and neck cancer: A meta-analysis implementing a mendelian randomization approach",
abstract = "Alcohol drinkinga thigh doses is a risk factor for head and neck cancer, and exposure to acetaldehyde, the principle metabolite of alcohol, is supposed to account for the increased risk. Individuals homozygous for the *2 variant allele of aldehyde dehydrogenase 2 (ALDH2) are unable tometabolize acetaldehyde, which prevents them from alcohol drinking, whereas *1*2 have 6-fold higher blood acetaldehyde concentration postalcohol consumption with respect to *1*1. Accordingto the concept of Mendelian randomization, because this polymorphism is distributed randomly duringg amete formation, its association with head and neck cancer should be not confounded by smoking. We carried out a meta-analysis of ALDH2 and head and neck cancer searchingfo r relevant studies on Medline and Embase up to January 31, 2008, and investigated the consistency between the expected odds ratio (OR) amongd rinkers from the largest pooled analysis amongne ver smokers and the observed OR from thismeta-analysis by an interaction test. Six studies were selected (945 cases, 2,917 controls). The OR of head and neck cancer among *2*2 was 0.53 [95{\%} confidence interval (95{\%} CI), 0.28-1.00] relative to *1*1 and 1.83 (95{\%} CI, 1.21-2.77) among *1*2. The expected OR for head and neck cancer due to alcohol intake among *1*1 was 1.38 (95{\%} CI, 0.88-2.17) and the observed OR among *1*1 compared with 2*2 from this meta-analysis was 1.88 (95{\%} CI, 1.00-3.57; P for interaction = 0.43). Besides showing the effectiveness of the Mendelian randomization approach, these findings support the theory that alcohol increases head and neck cancer risk through the carcinogenic action of acetaldehyde.",
author = "Stefania Boccia and Mia Hashibe and Paola Gall{\`i} and {De Feo}, Emma and Takahiro Asakage and Tomoko Hashimoto and Akio Hiraki and Takahiko Katoh and Takeshi Nomura and Akira Yokoyama and {Van Duijn}, {Cornelia M.} and Gualtiero Ricciardi and Paolo Boffetta",
year = "2009",
month = "1",
doi = "10.1158/1055-9965.EPI-08-0462",
language = "English",
volume = "18",
pages = "248--254",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Aldehyde dehydrogenase 2 and head and neck cancer

T2 - A meta-analysis implementing a mendelian randomization approach

AU - Boccia, Stefania

AU - Hashibe, Mia

AU - Gallì, Paola

AU - De Feo, Emma

AU - Asakage, Takahiro

AU - Hashimoto, Tomoko

AU - Hiraki, Akio

AU - Katoh, Takahiko

AU - Nomura, Takeshi

AU - Yokoyama, Akira

AU - Van Duijn, Cornelia M.

AU - Ricciardi, Gualtiero

AU - Boffetta, Paolo

PY - 2009/1

Y1 - 2009/1

N2 - Alcohol drinkinga thigh doses is a risk factor for head and neck cancer, and exposure to acetaldehyde, the principle metabolite of alcohol, is supposed to account for the increased risk. Individuals homozygous for the *2 variant allele of aldehyde dehydrogenase 2 (ALDH2) are unable tometabolize acetaldehyde, which prevents them from alcohol drinking, whereas *1*2 have 6-fold higher blood acetaldehyde concentration postalcohol consumption with respect to *1*1. Accordingto the concept of Mendelian randomization, because this polymorphism is distributed randomly duringg amete formation, its association with head and neck cancer should be not confounded by smoking. We carried out a meta-analysis of ALDH2 and head and neck cancer searchingfo r relevant studies on Medline and Embase up to January 31, 2008, and investigated the consistency between the expected odds ratio (OR) amongd rinkers from the largest pooled analysis amongne ver smokers and the observed OR from thismeta-analysis by an interaction test. Six studies were selected (945 cases, 2,917 controls). The OR of head and neck cancer among *2*2 was 0.53 [95% confidence interval (95% CI), 0.28-1.00] relative to *1*1 and 1.83 (95% CI, 1.21-2.77) among *1*2. The expected OR for head and neck cancer due to alcohol intake among *1*1 was 1.38 (95% CI, 0.88-2.17) and the observed OR among *1*1 compared with 2*2 from this meta-analysis was 1.88 (95% CI, 1.00-3.57; P for interaction = 0.43). Besides showing the effectiveness of the Mendelian randomization approach, these findings support the theory that alcohol increases head and neck cancer risk through the carcinogenic action of acetaldehyde.

AB - Alcohol drinkinga thigh doses is a risk factor for head and neck cancer, and exposure to acetaldehyde, the principle metabolite of alcohol, is supposed to account for the increased risk. Individuals homozygous for the *2 variant allele of aldehyde dehydrogenase 2 (ALDH2) are unable tometabolize acetaldehyde, which prevents them from alcohol drinking, whereas *1*2 have 6-fold higher blood acetaldehyde concentration postalcohol consumption with respect to *1*1. Accordingto the concept of Mendelian randomization, because this polymorphism is distributed randomly duringg amete formation, its association with head and neck cancer should be not confounded by smoking. We carried out a meta-analysis of ALDH2 and head and neck cancer searchingfo r relevant studies on Medline and Embase up to January 31, 2008, and investigated the consistency between the expected odds ratio (OR) amongd rinkers from the largest pooled analysis amongne ver smokers and the observed OR from thismeta-analysis by an interaction test. Six studies were selected (945 cases, 2,917 controls). The OR of head and neck cancer among *2*2 was 0.53 [95% confidence interval (95% CI), 0.28-1.00] relative to *1*1 and 1.83 (95% CI, 1.21-2.77) among *1*2. The expected OR for head and neck cancer due to alcohol intake among *1*1 was 1.38 (95% CI, 0.88-2.17) and the observed OR among *1*1 compared with 2*2 from this meta-analysis was 1.88 (95% CI, 1.00-3.57; P for interaction = 0.43). Besides showing the effectiveness of the Mendelian randomization approach, these findings support the theory that alcohol increases head and neck cancer risk through the carcinogenic action of acetaldehyde.

UR - http://www.scopus.com/inward/record.url?scp=58349122910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58349122910&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0462

DO - 10.1158/1055-9965.EPI-08-0462

M3 - Article

C2 - 19124505

AN - SCOPUS:58349122910

VL - 18

SP - 248

EP - 254

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -